Thanks for emailing that article!
Photos from the Glaucoma 360 New Horizons Forum, February 1, 2013 at the Palace Hotel in San Francisco.
(L-R) Keynote Speaker Louis Cantor, MD with Glaucoma 360 Co-Chairs Adrienne Graves, PhD and Andrew Iwach, MD
(L-R) Wiley A. Chambers, MD (FDA panelist) with H. Dunbar Hoskins, Jr., MD (GRF co-founder) and Kuldev Singh, MD, MPH (Stanford University Medical Center)
(L-R) Debra Lappin, JD with Anne Coleman, MD, PhD and Ruth Williams, MD
Gil Kliman, MD (left) and Wende Hutton share their views during the venture capital panel discussion.
Emmett Cunningham, Jr., MD, PhD, MPH (Clarus Ventures) interviewed Anthony P. Adamis, MD (Genentech) on the topic of driving discovery to clinical success.
The "New Horizons in Glaucoma Devices" panel was moderated by Ike Ahmed, MD, FRCS (far left) who spoke on "The Future of Glaucoma Surgery."
Barbara Wirostko, MD spoke about "real-life challenges in developing outflow drugs" for glaucoma.
Kuldev Singh, MD, MPH moderated the industry panel discussion on glaucoma pharmaceuticals.
Thomas van Haarlem, MD (left) and John Grunden, PharmD share ideas during a break in the meeting.
Last reviewed on October 29, 2017